In 2002, a man named Lu Yong was diagnosed with Leukemia. Unable to financially support the price of the brand-named drugs, he discovered a generic drug with almost the same effects but much cheaper in India and quickly resorted to that. Two years later, he was imprisoned for importing the generic drugs and selling them to other patients as he violated the patent law - a law that seeks to protect the intellectual property in the healthcare industry. This perpetuated large discussions on whether or not pharmaceutical patents should be abolished. Although Lu found a way to counter the…